Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile Infection
Authors:
- 23 July 2014
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (1) , 181-185
Abstract
Restoring normal fecal flora through intestinal microbiota transplantation (IMT) was successful in curing recurrent Clostridium difficile infection (CDI). However, only a few cases have been reported of IMT being utilized for the treatment of severe or fulminant CDI. Is IMT a simple and effective treatment for severe and recurrent CDI? In this retrospective study, we report 14 patients with severe CDI refractory to conventional medical therapy, who underwent IMT. Fresh donor stool specimen was manually homogenized with warm tap water, filtered through gauze and then instilled through nasogastric tube (NGT). The primary outcome was clinical cure, defined as less than 3 loose bowel movements a day on day 7 after IMT and no need for further CDI therapy. The secondary outcomes were recurrence of CDI within 100 days of IMT and 30-day mortality after IMT. Descriptive statistics were done. Fourteen patients with severe and refractory CDI received IMT. Mean age was 73.4 ± 11.9 years (range 52–92). IMT was given via NGT in 13 of the 14 patients. Eleven patients (79 %) achieved cure after IMT. No recurrence was seen in the patients who responded to IMT and were alive within the 100 day follow-up period. IMT was well tolerated. The 30-day all-cause mortality was 29 %, all 4 patients died as a result of their underlying cancer. No patients died as a result of CDI or IMT. IMT performed at the bedside via NGT is effective and safe for the treatment of severe and refractory CDI, and prevents recurrence.Keywords
This publication has 23 references indexed in Scilit:
- Attributable Burden of Hospital-OnsetClostridium difficileInfection: A Propensity Score Matching StudyInfection Control & Hospital Epidemiology, 2013
- Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unitEuropean Journal of Gastroenterology & Hepatology, 2013
- Duodenal Infusion of Donor Feces for RecurrentClostridium difficileNew England Journal of Medicine, 2013
- Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus VancomycinClinical Infectious Diseases, 2012
- Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infectionAmerican Journal of Health-System Pharmacy, 2012
- Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficileInfectionCase Reports in Infectious Diseases, 2012
- Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis.2012
- Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile InfectionClinical Infectious Diseases, 2011
- Toll-Like Receptor 5 Stimulation Protects Mice from Acute Clostridium difficile ColitisInfection and Immunity, 2011
- Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated DiarrheaThe Journal of Infectious Diseases, 2008